Intellia Therapeutics Inc buy William Blair
Start price
25.03.23
/
50%
€35.09
Target price
25.03.24
-
Performance (%)
-29.81%
End price
26.03.24
€24.63
Summary
This prediction ended on 26.03.24 with a price of €24.63. The prediction for Intellia Therapeutics Inc disappointed with a performance of -29.81%. William_Blair has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. William_Blair has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | 6.387% | 6.387% | 94.172% | -63.526% |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % | 49,79 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % | 88,25 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % | 61,92 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % | 63,54 % |
Comments by William_Blair for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von William_Blair gewählte maximale Laufzeit wurde überschritten
Current prediction by William_Blair for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.98
02.03.26
02.03.26
-
02.03.27
02.03.27
-2.47%
08:00
08:00
